Form D · Pharmaceuticals
NanoPharmaceuticals LLC
Troy, NY · CIK 0001594078
Offering snapshot reported Feb 4, 2025 · SEC filing
- Reported sold
- $623K Offering amount: $2.4M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jan 23, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 4, 2025 | Initial | $622,500 | No comparison | 12 | SEC filing |
| Aug 20, 2018 | Initial | $1,332,240 | No comparison | 8 | SEC filing |
| Apr 24, 2017 | Initial | $1,995,975 | No comparison | 16 | SEC filing |
| Feb 3, 2014 | Initial | $2,622,500 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-537250
Source: Form D, filed Feb 4, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Davis | Director |
| T. Gregory Dewey | Director |
| James Gozzo | Director, Executive |
| Eliza Mc Kinney | Executive |
| Shaker Mousa | Director |
| Eliza J. Parker | Executive |
| Michael J. Rosenthal | Director, Executive |
| Carl Walkey | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
185 Jordan Road Suite 4
Troy, NY, 12180
Troy, NY, 12180